KBC Group NV Lowers Stock Holdings in HealthEquity, Inc. $HQY

KBC Group NV lessened its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 35.7% during the second quarter, HoldingsChannel reports. The firm owned 2,411 shares of the company’s stock after selling 1,341 shares during the quarter. KBC Group NV’s holdings in HealthEquity were worth $253,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in HQY. SBI Securities Co. Ltd. increased its stake in HealthEquity by 25,100.0% in the second quarter. SBI Securities Co. Ltd. now owns 756 shares of the company’s stock valued at $79,000 after purchasing an additional 753 shares during the last quarter. Allworth Financial LP boosted its stake in HealthEquity by 283.1% in the 2nd quarter. Allworth Financial LP now owns 747 shares of the company’s stock worth $78,000 after buying an additional 552 shares during the last quarter. Future Fund LLC purchased a new stake in HealthEquity in the 2nd quarter valued at about $2,149,000. Campbell & CO Investment Adviser LLC grew its holdings in HealthEquity by 329.0% in the 2nd quarter. Campbell & CO Investment Adviser LLC now owns 16,918 shares of the company’s stock valued at $1,772,000 after buying an additional 12,974 shares during the period. Finally, Fox Run Management L.L.C. acquired a new position in shares of HealthEquity during the 2nd quarter valued at about $915,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently issued reports on HQY. JPMorgan Chase & Co. raised their target price on shares of HealthEquity from $125.00 to $126.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 3rd. Royal Bank Of Canada lifted their price target on shares of HealthEquity from $109.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, September 3rd. KeyCorp lowered their price objective on shares of HealthEquity from $125.00 to $120.00 and set an “overweight” rating for the company in a research note on Wednesday, October 8th. Weiss Ratings restated a “hold (c+)” rating on shares of HealthEquity in a report on Wednesday, October 8th. Finally, Jefferies Financial Group increased their target price on HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a research report on Wednesday, September 3rd. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $119.00.

HealthEquity Price Performance

HQY opened at $102.74 on Wednesday. HealthEquity, Inc. has a 52-week low of $74.07 and a 52-week high of $116.65. The company has a 50 day moving average of $94.36 and a two-hundred day moving average of $96.24. The company has a market cap of $8.85 billion, a P/E ratio of 62.27, a P/E/G ratio of 1.36 and a beta of 0.47. The company has a quick ratio of 4.23, a current ratio of 4.23 and a debt-to-equity ratio of 0.47.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Tuesday, September 2nd. The company reported $0.92 earnings per share for the quarter, meeting the consensus estimate of $0.92. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. The business had revenue of $325.80 million for the quarter, compared to analyst estimates of $320.68 million. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. On average, analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Insider Transactions at HealthEquity

In other news, EVP Delano Ladd sold 6,000 shares of the company’s stock in a transaction dated Friday, September 19th. The stock was sold at an average price of $94.11, for a total value of $564,660.00. Following the completion of the sale, the executive vice president owned 79,456 shares of the company’s stock, valued at $7,477,604.16. This represents a 7.02% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Michael Henry Fiore sold 1,781 shares of the firm’s stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total value of $157,102.01. Following the sale, the executive vice president owned 49,795 shares in the company, valued at approximately $4,392,416.95. The trade was a 3.45% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 9,281 shares of company stock worth $859,867. 1.50% of the stock is currently owned by insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.